In children evaluated for a possible macrolide allergy, intradermal testing with a suspected culprit drug at 0.05 mg/mL showed high specificity (92.7%) but limited sensitivity. To confirm an allergy ...

NanoPass Technologies Ltd. ("NanoPass"), a pioneer in intradermal delivery solutions for vaccines, announced today that it has entered into a license agreement for the supply of MicronJet600™, its ...

Allergic diseases represent a group of immune mediated disorders mainly attributed but not limited to IgE, Th2 cytokines and certain cell subsets. Breakthroughs in identifying new biomarkers, novel ...